Skip to main content
. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403

Figure 1.

Figure 1

Study design. 5-FU, 5-fluorouracil; ECOG PS, Eastern Cooperative Oncology Group Performance Status; LV, L-Leucovorin; PD, disease progression.